Stay updated on Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial page.

Latest updates to the Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial page
- Check4 days agoChange DetectedAdded a prominent notice about a lapse in government funding and potential update delays. Updated the page revision metadata to v3.4.1 with recent dates.SummaryDifference0.5%

- Check11 days agoChange DetectedShow glossary is now displayed; the labels were updated to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and the revision tag updated to 'Revision: v3.4.0', replacing the previous 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page shows a revision update from v3.3.3 to v3.3.4; no user-visible changes to study details or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check47 days agoChange DetectedFooter updates include Revision: v3.3.3; the HHS Vulnerability Disclosure link and Revision: v3.3.2 text were removed.SummaryDifference0.1%

- Check62 days agoChange DetectedIPD data-sharing section updated: Ipsen's data transparency link was added and data availability timing clarified. References to Vivli were removed.SummaryDifference0.3%

- Check76 days agoChange DetectedPublications section updated to clarify that publications are automatically filled from PubMed and added Revision: v3.3.2. The prior PubMed-source phrasing and Revision: v3.2.0 reference were removed.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial page.